Prescription drug · UNAPPROVED DRUG OTHER
Sodium Sulfacetamide NDC 44523-606
Sulfacetamide sodium 100 mg/mL · Liquid · Topical · BioComp Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 44523-606-12 | 44523060612 | 355 mL in 1 BOTTLE, PLASTIC (44523-606-12)Marketed from Jan 7, 2013 | |
| 44523-606-16 | 44523060616 | 473 mL in 1 BOTTLE, PLASTIC (44523-606-16)Marketed from Jan 7, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Sulfacetamide
- Generic name (nonproprietary)
- sodium sulfacetamide
- Active ingredients
- Sulfacetamide sodium — 100 mg/mL
- Dosage form
- Liquid
- Route
- Topical
- Labeler
- BioComp Pharma, Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonamides (Chemical structure)
- Identifiers
- Product ID 44523-606_4629294b-c757-6477-e063-6294a90a3d5dSPL ID 4629294b-c757-6477-e063-6294a90a3d5dSPL set ID d8954bfa-2acf-445a-9810-62cfd5d469b3RxCUI 1006107UNII 4NRT660KJQ
- Pharmacologic class
- Sulfonamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N444523060612followed by a unit qualifier and the quantityPackage 44523-0606-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff). It also is indicated for the treatment of secondary bacterial infections of the skin due to organisms susceptible to sulfonamides.
Excerpt only. Read the full label for complete information.